Avalyn Pharma Inc
NASDAQ: AVLN9 known investors
Avalyn Pharma is a clinical-stage biopharmaceutical company developing targeted inhaled therapies for patients with rare lung diseases, including pulmonary fibrosis and other interstitial lung diseases. Its lead inhaled therapies have advanced through global Phase 2 development for pulmonary fibrosis.
BiotechHealthtechMedical Devices
Founders & leadership
LB
Lyn BaranowskiinChief Executive Officer
Investors · 9
Andera PartnersParis
Catalio Capital Management, LPNew York
F-Prime CapitalCambridge · $3M – $10M
InVivium CapitalChicago
Norwest Venture PartnersMenlo Park · $10M – $30M
RiverVest Venture PartnersSt. Louis · $500K – $3M
SR One Capital ManagementRedwood City
Vida VenturesLos Angeles
Novo HoldingsreportedCopenhagen · $1.1M – $54M
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Competitors · 4
by search overlapAlnylam26 shared keywordsAlnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
Bioworld15 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Eledon15 shared keywordsEledon develops tegoprubart, an anti-CD40L antibody in clinical development for preventing rejection in organ transplant recipients. The company focuses on improving long-term graft survival and quality of life for transplant recipients across kidney, liver, and xenotransplantation.
Robinhood14 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with Avalyn Pharma Inc for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Avalyn Pharma Inc do?
- Avalyn Pharma is a clinical-stage biopharmaceutical company developing targeted inhaled therapies for patients with rare lung diseases, including pulmonary fibrosis and other interstitial lung diseases. Its lead inhaled therapies have advanced through global Phase 2 development for pulmonary fibrosis.
- Who are Avalyn Pharma Inc's investors?
- Avalyn Pharma Inc's investors include Andera Partners, Catalio Capital Management, LP, F-Prime Capital, InVivium Capital, Norwest Venture Partners, RiverVest Venture Partners, SR One Capital Management, Vida Ventures and 1 more.